Vanderbilt Heart and Vascular Institute Archives
Aug. 18, 2016—The old adage that age is just a number actually became a lifesaver for 71-year-old Rex Parton.
Aug. 4, 2016—Vanderbilt University Medical Center’s heart transplant program is ranked No. 2 nationwide in volume for its combined adult and pediatric procedures, according to the most recent data released by Organ Procurement and Transplant Network (OPTN) in July.
Feb. 18, 2016—Because donor organs are scarce, understanding the mortality risk associated with heart transplantation is an important consideration when evaluating patients for transplant.
Nov. 5, 2015—After serving in an interim capacity, Walter Clair, M.D., MPH, associate professor of Medicine and medical director of Cardiac Electrophysiology, has been named executive medical director of the Vanderbilt Heart and Vascular Institute (VHVI).
Oct. 15, 2015—Ashish Shah, M.D., has joined Vanderbilt Heart and Vascular Institute (VHVI) as director of Heart Transplant and Mechanical Circulatory Support.
Jun. 17, 2015—Vanderbilt Heart and Vascular Institute now offers patients with atrial fibrillation (AF) an alternative treatment to reduce their risk of stroke, potentially avoiding the long-term use of blood thinners such as warfarin.
Jun. 11, 2015—Two vastly different causes of heart failure, both of which can devastate a patient’s life, are being studied at Vanderbilt University Medical Center thanks, in part, to the generosity of a grateful patient whose own damaged heart was repaired at Vanderbilt more than five years ago.
Feb. 19, 2015—Despite prior epidemiologic and experimental data to the contrary, new research shows that vitamin D supplementation does not reduce blood pressure in individuals with prehypertension or stage I hypertension and vitamin D deficiency.
Feb. 5, 2015—Vanderbilt is embarking on an observational study to define and understand how a promising treatment for multiple myeloma affects the heart.